We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Cellomics Introduces Neuronal Profiling BioApplication
Product News

Cellomics Introduces Neuronal Profiling BioApplication

Cellomics Introduces Neuronal Profiling BioApplication
Product News

Cellomics Introduces Neuronal Profiling BioApplication

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Cellomics Introduces Neuronal Profiling BioApplication"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Cellomics, a unit of Fisher Biosciences, has introduced image-analysis software for neurobiology that provides real-time measurements for neuronal morphology and neurite outgrowth in vitro.

The fully integrated software, working with Cellomics' ArrayScan® or KineticScan® HCS Readers automatically extracts all necessary information on visualized neurons and neurites as well as non-neuronal cells.

The software is managed through Cellomics' High Content Information (HCi™) software.

"Cellomics' Neuronal Profiling BioApplication is unique because it analyzes images on the fly, providing immediate results," said Ron Lowy, president and chief executive officer of Fisher Biosciences.

"It is a valuable time-saving tool for our customers who want to conduct neurobiology studies using HCS."
Cellomics' neuronal profiling technology assists in analyzing neurite growth or neuronal differentiation.

This application will serve researchers in biotechnology and pharmaceutical companies developing and testing potential drugs for neurological diseases, toxicity, and spinal cord injuries; academic researchers studying neuronal diseases and processes; and environmental scientists conducting product-safety testing.

Cellomics claims that, with the Neuronal Profiling BioApplication, a researcher can easily retrieve information on cell population, along with many other details, in a fraction of the time used in conventional methods. The technology eliminates the need to manually count neurites.

"The new Neuronal Profiling BioApplication gives us more parameters for quantifying neuronal outgrowth," said Michael Bova, principal scientist and team leader at Elan Pharmaceuticals.

Bova and his team are using the Cellomics tool in studying both primary and neuronal cultures and SH-SY5Y cells to discover how compounds alter or modify neuronal outgrowth.

"The cell and nuclear segmentation features enable us to quantify neuronal outgrowth with more precision, flexibility and confidence."